High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: Results in vivo and analysis of point mutations

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 6, 2002, Pages 664-669

  Checchi, F ^a   Durand, R ^b   Balkan, S ^a   Vonhm, B T ^c   Kollie, J Z ^a   Biberson, P ^a   Baron, E ^a   Le Bras, J ^b   Guthmann, Jean Paul ^d  

^a Européens sans frontières   (France)

^b BICHAT HOSPITAL   (France)

^c MINISTRY OF HEALTH AND SOCIAL WELFARE   (Liberia)

^d EPICENTRE   (France)

Author keywords

Chemotherapy; Chloroquine; dhfr; dhps; Liberia; Malaria; pfcrt; Plasmodium falciparum; Resistance; Sulfadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; PROTOZOAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IN VIVO STUDY; INFANT; LIBERIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEDICAL INFORMATION; PARASITE ISOLATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; REINFECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0344770924     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90346-9     Document Type: Article

References (27)

1. Basco, L. K., Tahar, R., Keundjian, A. & Ringwald, P. (2000). Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. Journal of Infectious Diseases, 182, 624-628.
2. Bloland, P. B. (2001). Drug resistance in malaria. Geneva: World Health Organization, WHO/CDS/CSR/DRS/2001.4.
3. Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B. O., Steketee, R. J. & Campbell, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932-937.
4. Bojang, K. A., Schneider, G., Forck, S., Obaro, K., Jaffar, S., Pinder, M., Rowley, J. & Greenwood, B. M. (1998). A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 73-76.
5. Checchi, F., Balkan, S., Vonhm, B. T., Massaquoi, M., Biberson, P., Eldin de Pecoulas, P., Brasseur, P. & Guthmann, J.-P. (2002). Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 670-673.
6. Diourté, Y., Djimdé, A., Doumbo, O. K., Sagara, I., Coulibaly, Y., Dicko, A., Diallo, M., Diakité, M., Cortese, J. F. & Plowe, C. V. (1999). Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine and Hygiene, 60, 475-478.
7. Doumbo, O. K., Kayentao, K., Djimde, A., Cortese, J. F., Diourte, Y., Konaré, A., Kublin, J. G. & Plowe, C. V. (2000). Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. Journal of Infectious Diseases, 182, 993-996.
8. Durand, R., Eslahpazire, J., Jafari, S., Delabre, J. F., Marmorat-Khuong, A., Di Piazza, J. P. & Le Bras, J. (2000). Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy, 44, 3461-3464.
9. Durand, R., Jafari, S., Vauzelle, J., Delabre, J. F., Jesic, Z. & Le Bras, J. (2001). Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Molecular and Biochemical Parasitology, 114, 95-102.
10. Foster, S. D. (1991). Pricing, distribution, and use of antimalarial drugs. Bulletin of the World Health Organization, 69, 349-363.
11. Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A. G., Rogerson, S. J., Lescano, A. G., Molyneux, M. E., Winstanley, P. A., Chimpeni, P., Taylor, T. E. & Plowe, C. V. (2002). Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of falciparum malaria. Journal of Infectious Diseases, 185, 380-388.
12. Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E. & Watkins, W. (2001). Chlorproguanildapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet, 358, 1218-1223.
13. Nagesha, H. S., Din-Syafruddin, Casey, G. J., Susanti, A. I., Fryauff, D. J., Reeder, J. C. & Cowman, A. F. (2001). Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 43-49.
14. Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H. & Watkins, W. M. (2000). Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteoate synthase of Kenyan parasites. Antimicrobial Agents and Chemotherapy, 44, 991-996.
15. Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O. & Wellems T. E. (1995). Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene, 52, 565-568.
16. Rønn, A. M., Msageni, H. A., Mhina, J., Wernsdorfer, W. H. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
17. Slutsker, L., Taylor, T. E., Wirima, J. J. & Steketee, R. W. (1994). In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 548-551.
18. Snounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N. & Viriyakosol, S. (1999). Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 369-374.
19. Snow, R. W., Craig, M., Deichmann, U. & Marsh, K. (1999). Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of the World Health Organization, 77, 624-640.
20. Staedke, S. G., Kamya, M. R., Dorsey, G., Gasasira, A., Ndeezi, G., Charlebois, E. D. & Rosenthal, P. J. (2001). Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum. malaria in Kampala, Uganda: a randomised trial. Lancet, 358, 368-374.
21. Trape, J.-F. (2001). The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene, 64, supplement 1, 12-17.
22. Triglia, T., Menting, J. G. T., Wilson, C. & Cowman, A. F. (1997). Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA, 94, 13944-13949.
23. Villadary, I., Paquet, C., Hemelsdael, E., Blanchard, G. & Saki, Z. M. (1997). In vivo drug sensitivity of Plasmodium falciparum in the Tabou region of Ivory Coast. Bulletin de la Société de Pathologie Exotique, 90, 10-13.
24. Wellems, T. E. & Plowe, C. V. (2001). Chloroquine-resistant malaria. Journal of Infectious Diseases, 184, 770-776.
25. White, N. J. & Olliaro, P. (1996). Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today, 12, 399-401.
26. White, N. J., Nosten, F., Looareesuwan, S., Watkins, W. M., Marsh, K., Snow, R. W., Kokwaro, G., Ouma, J., Hien, T. T., Molyneux, M. E., Taylor, T. E., Newbold, C. I., Ruebush, T. K., Danis, M., Greenwood, B. M., Anderson, R. M. & Olliaro, P. (1999). Averting a malaria disaster. Lancet, 353, 1965-1967.
27. WHO (1996). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva: World Health Organization, WHO/MAL/96.1077.